Navigating the complexity of compliance review of UK/EU product communications for rare diseases By Marcelo Vaz, Vice President of Medical Services at [...]By TMC|2025-03-17T13:38:26+00:0010 March 2025|In the media|0 Comments Read More
TMC Pharma champions holistic approach to medical services in rare disease drug development Gallery TMC Pharma champions holistic approach to medical services in rare disease drug development In the media TMC Pharma champions holistic approach to medical services in rare disease drug developmentBy TMC|2024-11-08T15:31:31+00:0015 March 2024|In the media|0 Comments Read More
European Biopharmaceutical Review article 29 February 2024 Gallery European Biopharmaceutical Review article 29 February 2024 In the media European Biopharmaceutical Review article 29 February 2024By TMC|2024-11-08T15:32:02+00:006 March 2024|In the media|0 Comments Read More
Clinical Trials Arena article 29 February 2024 Gallery Clinical Trials Arena article 29 February 2024 In the media Clinical Trials Arena article 29 February 2024By TMC|2024-11-08T15:32:09+00:001 March 2024|In the media|0 Comments Read More
PharmaTimes article 29 February 2024 Gallery PharmaTimes article 29 February 2024 In the media PharmaTimes article 29 February 2024By TMC|2024-11-08T15:32:13+00:001 March 2024|In the media|0 Comments Read More